Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

NCT06650501 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT06650501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06650501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Phase 4
Overall status
Recruiting
Start date
January 15, 2026
Completion date
January 31, 2030
Enrollment
300 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

s. aureus bacteremia, s. aureus bloodstream infection, staphylococcus aureus bacteremia, staphylococcus aureus bloodstream infection, staphylococcus aureus endocarditis, staphylococcus aureus septicemia